TRANSARTERIAL CHEMOEMBOLIZATION
Clinical trials for TRANSARTERIAL CHEMOEMBOLIZATION explained in plain language.
Never miss a new study
Get alerted when new TRANSARTERIAL CHEMOEMBOLIZATION trials appear
Sign up with your email to follow new studies for TRANSARTERIAL CHEMOEMBOLIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets unresectable liver cancer
Disease control Not yet recruitingThis study tests a new combination treatment for people with advanced liver cancer that cannot be surgically removed. The treatment includes a procedure that delivers chemotherapy directly to the tumor (TACE) plus two drugs that boost the immune system and block blood vessel grow…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 17, 2026 07:43 UTC
-
New combo therapy aims to shrink untreatable liver tumors
Disease control Not yet recruitingThis study tests a new combination of drugs and procedures for people with liver cancer that cannot be removed by surgery. About 38 participants will receive a low-dose immunotherapy drug (atezolizumab) plus a low-dose anti-angiogenic drug (bevacizumab) along with two liver-direc…
Matched conditions: TRANSARTERIAL CHEMOEMBOLIZATION
Phase: NA • Sponsor: Third Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 12, 2026 12:03 UTC